Approval · Notice of Compliance 1304 · 2000
MS CONTIN: Notice of Compliance 1304
Issued July 18, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1304
- Date
- July 18, 2000
- Company
- Purdue Frederick
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised dosing
- Therapeutic class
- Opioid analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MS CONTIN | Not yet assigned | — |
Medicinal ingredients
- MORPHINE SULFATE 30 MG per SUP
- MORPHINE SULFATE 60 MG per SUP
- MORPHINE SULFATE 100 MG per SUP
- MORPHINE SULFATE 200 MG per SUP
- MORPHINE SULFATE 300 MG per SUP